26 October 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Shaun Hopgood as chief technology officer.
With over 30 years of technology and transformation experience from multiple industry sectors, including the last 20 years spent in health and life sciences, Shaun brings a wealth of knowledge and expertise to support the future growth of Qinecsa as it executes its strategy to become the global leader in pharmacovigilance solutions.
“Qinecsa is on an exciting journey to bring together best-in-class technologies and services to create world-leading, truly end-to-end drug safety solutions,” commented Shaun Hopgood. “I look forward to leading our expert technology teams and creating a robust framework to support the development of ground-breaking technology solutions while ensuring data security and compliance.”
“We are delighted to welcome Shaun to Qinecsa’s leadership team. His extensive background in technology and pharmaceutical services and proven track record of leveraging technology to drive business transformation will be instrumental in supporting our growth,” commented John Gillie, CEO of Qinecsa Solutions. “Shaun’s expertise will create a solid technology foundation on which to build out product strategy through internally developed solutions as well as through future acquisitions and ensure that we continue at the forefront of specialist pharmacovigilance service and technology provision.”
About Qinecsa Solutions
Qinecsa specializes in technology-led end-to-end pharmacovigilance solutions. We are trusted, global partners bringing together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions. Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. Working with life science companies we drive progress to continue protecting lives.
